Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


Johnson & Johnson will pay $181 million in fees to Houston law firm

Award to Bailey Perrin Bailey is tied to Risperdal fraud case

A small law firm is coming into some big cash.

Arkansas state judge Tim Fox has ordered Johnson & Johnson (J&J) to pay $181 million in fees to Houston-based Bailey Perrin Bailey for the work it did on a state Medicare fraud case involving the antipsychotic drug Risperdal. In that case, Fox fined J&J $1.1 billion for downplaying and hiding the risks associated with Risperdal, as well as marketing the drug for unapproved uses. As a result of J&J’s deceptive practices, Fox said, Arkansas’ Medicaid insurance program overpaid for the drug.

The $181 million represents a 15 percent contingency fee that the Arkansas Attorney General’s Office agreed to pay to Bailey Perrin Bailey, which assigned up to 10 lawyers and five paralegals to the case. The 23-lawyer firm specializes in product liability, personal injury and defective drug claims.

Johnson & Johnson spokeswoman Teresa Mueller calls the fees “excessive” and says the company plans to appeal them.

“The fee awarded represents about $19,700 per hour for each of the outside attorneys and staff who worked on the case for the state, based on our reconstruction of their actual time,” Mueller said in a statement.

Meanwhile, a spokesman for the attorney general’s office says the ruling “has nothing whatsoever to do with reconstruction of time,” but everything to do with J&J’s deceptive and illegal actions.

For more InsideCounsel coverage of the J&J Risperdal litigation, read:

Johnson & Johnson to pay $181 million to settle Risperdal case

J&J and DOJ close to settlement in Risperdal case

Arkansas judge fines J&J $1.1 billion in Risperdal suit

Texas’ deal in Risperdal case finalized

Johnson & Johnson heads back to court in Risperdal suit

No deal in Johnson & Johnson Risperdal case

J&J may pay more than $1 billion in Risperdal case

Documents Reveal Johnson& Johnson's Plan to Market an Anti-Psychotic as a Dementia Drug to Elderly

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.